Jan Tuckermann

32PUBLICATIONS
149CO-AUTHORS
Molecular targetsMolecular medicineBiomechanicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 06, 2026
Inhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass.

|Jul 23, 2025
JAK/STAT inhibition protects glucocorticoid receptor knockout mice from lethal malaria-induced hypoglycemia and hyperinflammation.

Fran Prenen, Leen Vandermosten, Sofie Knoops

|Feb 14, 2025
Basic and Clinical Scientists Working Together-Do We Make the Best of Both Worlds?

Willem F Lems, Athanasios D Anastasilakis, Christina Møller Andreasen

|Jan 01, 2025
Tau(t)ing glucocorticoid binding.

Sabine Vettorazzi, Jan Tuckermann

|Aug 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation.

Theresa Landspersky, Merle Stein, Mehmet Saçma

|Apr 10, 2024
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids.

Jean-Philippe Auger, Max Zimmermann, Maria Faas

Pageof 6

Frequent Collaborators

6 joint publications

Anita Ignatius

4 joint publications

Mubashir Ahmad

3 joint publications

Lena Steppe

3 joint publications

Melanie Haffner-Luntzer